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Abstract
I In nt tr ro od du uc ct ti io on n: : Surgical repair of an aortic aneurysm might be complicated by
spinal cord injury and paraplegia. Since β-adrenoreceptor agonists showed
neuroprotective effects, the study was designed to investigate the effect of
clenbuterol on post-aortic clamping paraplegia and to identify if there is
hyperemia associated with paraplegia. 
M Ma at te er ri ia al l   a an nd d   m me et th ho od ds s: : Thirty rabbits were divided into two groups: 15 control
and 15 experimental (given clenbuterol 9 mg in drinking water 24 h prior to
surgery). All the animals were subjected to laparotomy whereas the abdominal
aorta was identified. Using a vascular clamp, the abdominal aorta was clamped
just distal to the renal arteries. Abdominal aortic blood flow was recorded with
a transonic flow meter. The neurological assessment was made according to
Tarlov’s Neurological Scale upon recovering from anesthesia. Anal sphincter
tonus and bladder sphincter function were also checked.
R Re es su ul lt ts s: :   Four rabbits (2 control and 2 experimental) developed complete
paraplegia within 30 min of cross-clamping of the aorta. Of the 13 controls, 77%
developed paraplegia, and of the 13 experimental rabbits administered clenbuterol
24 h prior to surgery with 22 min of aortic cross-clamping, 38% developed
paraplegia The rabbits which did not develop paraplegia had a minimal increase
in aortic blood flow, whereas the rabbits which developed paraplegia had
a significant increase in aortic blood flow measurements after aortic decamping. 
C Co on nc cl lu us si io on ns s: : Post-aortic clamping paraplegia is associated with hyperemia and
clenbuterol has a significant neuroprotective effect, obviously by preventing an
increase in aortic blood flow following unclamping.
K Ke ey y   w wo or rd ds s: : aortic clamping, hyperemia, clenbuterol, paraplegia.
Introduction
After the surgical repair of an aortic aneurysm, spinal cord injury with
paraplegia is among the most devastating and unpredictable complications.
The incidence of spinal cord injury as a complication of aortic aneurysm
repair is 3.0% to 18.0% [1-6]. Spinal cord injury can occur not only during
extensive thoracoabdominal aneurysm repair but also postoperatively,
causing delayed-onset paraplegia. Spinal cord ischemia is caused by aortic
cross-clamping and interruption of blood flow to the spinal cord via critical
intercostal arteries. Basically, various causes of spinal cord ischemia have
been suggested, including interference with pelvic blood supply, prolonged
aortic cross-clamping, prolonged suprarenal clamping, intraoperative
hypotension, throm  boembolic phenomena and interference with a low-
C Co or rr re es sp po on nd di in ng g   a au ut th ho or r: :
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origin arteria radicularis magna [3]. Moreover, the
causation of spinal cord ischemia during abdominal
aortic repair is thought to depend on clamping time,
reperfusion injury, and hemodynamics [1].
Cerebrospinal  fluid  drainage,  hypothermia,
monitoring of somatosensory and motor-evoked
potentials, intercostal artery reattachment, distal
aortic perfusion, and direct spinal cord cooling have
all  been  used  to  protect  against  spinal  cord
ischemia [7-11]. However, this complication remains
unpredictable and unpreventable [12-14]. 
In  reviewing  609  patients  who  underwent
surgical descending thoracic or thoracoabdominal
aortic aneurysm repair, it was found that the extent
of segmental artery sacrifice is the most powerful
predictor  of  paraplegia  risk  [15].  Fasudil  has
neuroprotective effects against ischemic spinal cord
injury  in  rabbits  by  reducing  the  number  of
infiltrating cells in the ventral horn and prolonging
the expression of eNOS [16]. Selective infusion of
sivelestat sodium hydrate (ONO-5046) directly into
the spinal cord via the lumbar arteries significantly
attenuated functional and morphological ischemia-
induced spinal cord injury [17]. The mitochondrial
K-ATP  channel  opener  diazoxide  improves
neurological function after spinal cord ischemia and
reperfusion by diminishing levels of reactive oxygen
species, decreasing DNA oxidative damage, and
inhibiting caspase-dependent and -independent
apoptotic pathways while preserving mitochondrial
structure [18]. Excitatory amino acid neurotoxicity
through the N-methyl-D-aspartate (NMDA) receptor
is no doubt the pathologic hallmark of ischemic and
postischemic spinal cord injury. The segmental
infusion  of  noncompetitive  NMDA  receptor
antagonist as an intraoperative spinoplegia could
have a protective effect on the spinal cord neurons
against excitotoxic neuronal injury in vivo [19].
Studies suggest that cyclooxygenase contributes
to  ischemic  neuronal  damage  and  that  cyclo-
oxygenase inhibitors may reduce injury. Intrathecal
ketorolac  may  be  of  therapeutic  potential  for
preventing  spinal  cord  ischemic  injury  during
thoracoabdominal aortic surgery [20]. The combined
use of CSF drainage and naloxone offers significant
protection against neurological deficits in patients
undergoing thoracoabdominal and thoracic aortic
replacement [21]. Tumor necrosis factor-α (TNF-α) is
one  of  the  important  contributing  factors  to
ischemia-induced spinal cord injury which can
induce necrosis and apoptosis of cells [22].
Additional damage to the spinal cord may occur
during the reperfusion period [14]. The β2-adre  -
noreceptor agonist clenbuterol is known to act as
a neuroprotective substance in the central nervous
system, and also reduces muscle atrophy after
denervation. In addition, β-adrenoreceptor agonists
provide neuroprotective effects after focal cerebral
ischemia in experimental settings, and improve
neurological  and  histological  outcomes  after
transient  focal  cerebral  ischemia  in  rats
independently  of  administration  route  [23].
Clenbuterol caused substantial enhancement of re  -
covery of locomotor function at severe levels of
injury of spinal cord [24]. Clenbuterol (0.01-0.5
mg/kg) reduced the cortical infarct volume in Long-
Evans rats as measured 7 days after permanent
occlusion of the middle cerebral artery [25].
This study was conducted to investigate the
possible protective effect of clenbuterol on post-
aortic clamping paraplegia and to identify if there
is  hyperemia  following  aortic  clamping,  and
whether this hyperemia has any role in patho-
genesis of paraplegia.
Material and methods
Thirty New Zealand rabbits weighing between 4kg
and 6kg were used for experimentation. The animals
were  divided  into  two  groups:  15  control  and 
15 experimental (given clenbuterol 9 mg in drinking
water 24 h prior to surgery). All the animals were
anesthetized  with  atropine  0.005  mg/kg  sub  -
cutaneously followed by ketamine 20 mg/kg intra  -
muscularly and xylazine 3 mg/kg intramuscularly.
Abdominal wall fur was clipped pre-operatively to
expose the abdomen wall skin. All rabbits were given
heparin at the dose of 70 units/kg 5 min prior to
surgery. Additional doses of ketamine and xylazine
were given during the procedure intravenously as
needed and there was no need for endotracheal
intubation or mechanical ventilation. All the rabbits
were kept on 100% oxygen during the procedure.
Following the preparation of the abdominal skin
with Betadine solution, a vertical midline incision
measuring 5 cm was made. The abdominal aorta
was  identified.  A transonic  flow  meter  probe
(Transonic Systems, Ithaca, NY) was placed 1 cm
below the renal arteries and direct blood flow
measurements were recorded at the infrarenal aorta
before and after aortic clamping (Figure 1). Normal
saline was used as an acoustic medium between
F Fi ig gu ur re e   1 1. .   The rabbit as an experimental model is
depicted, along with the Transonic Flowmeter probe
in situ, positioned for the infrarenal aortic flow
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the aorta and the probe. Flow measurements were
continuously  recorded  using  a 1BM386  micro-
computer  connected  to  the  flow  meter  in
conjunction with the appropriate software program.
The principle of the transonic flow meter is
dependent upon transit time ultrasound technology
(Figure 2). The data processor is shown in Figure 3.
The degree of reproducible ischemic injury was
established by cross-clamping the infrarenal aorta
for 22 min. Using a vascular clamp, the abdominal
aorta was clamped just distal to the renal arteries
for the specified time interval. Confirmation of
aortic occlusion was obtained by a zero reading of
the transonic flow meter. Abdominal aortic blood
flow was recorded at the time of declamping of the
aorta until the blood flow reading peaked and
returned to baseline. Following the experiment, the
abdominal  wall  was  closed  with  3-0  Dexon
absorbable sutures for fascial closure and 3-0 silk
sutures for skin closure.
All rabbits were observed for 24 h. The neurological
assessment  was  made  according  to  Tarlov’s
Neurological Scale (Table I) upon recovering from
anesthesia.  Anal  sphincter  tonus  and  bladder
sphincter function were also checked. All the animals
were euthanized at the completion of the study.
Animal handling, care and disposal met the guidelines
in the Principle of Laboratory Animal Care and Guide
for the Care of Laboratory Animals (National Institute
of Health Publication No. 86-23, revised 1983).
Results
Assessment of degree of paralysis of the hind
limbs  was  recorded  according  to  Tarlov’s
Neurological Scale (Table I). Four rabbits (2 control
and 2 experimental) developed complete paraplegia
within 30 min of cross-clamping of the aorta. Of the
13 controls, 77% developed paraplegia (Tarlov 0, 
n = 9; Tarlov 1, n = 1) and 23% did not develop
paraplegia (Tarlov 3, n = 1; Tarlov 4, n = 2). Of the
13 expe  rimental rabbits administered clenbuterol
24 h prior to surgery with 22 min of aortic cross-
clamping, 38% developed paraplegia (Tarlov 0, 
n = 3; Tarlov 1, n = 2), and 62% did not develop
paraplegia (Tarlov 3, n = 2; Tarlov 4, n = 6) (Figure 4).
The mean Tarlov score for the experimental group
was 2.461 ﾱ1.761 and for the control group 0.923
ﾱ1.605 (p < 0.05, p value 0.0147). The rabbits which
did not develop paraplegia had a minimal increase
in aortic blood flow (Figure 5), whereas the rabbits
which  developed  paraplegia  had  a significant
increase in aortic blood flow measurements after
aortic declamping (Figure 6). 
Discussion
The aortic flow measurements in the rabbits
with paraplegia showed a significant increase in
aortic flow following unclamping. Those rabbits with
no paraplegia had minimal increase in aortic flow.
There is a statistical difference between the control
and the experimental group regarding Tarlov’s
score. A higher score was found in the experimental
group as compared to the control group. It is clear
the: 1) hyperemia and increased blood flow after
the procedure were evident in animals who showed
paraplegia, supporting the view that reperfusion
injury might play a role in the pathogenesis of
paraplegia and 2) clenbuterol could protect against
paraplegia partly by attenuation of post-ischemic
hyperemia injury. 
The  exact  mechanism  of  postoperative
paraplegia is not entirely clear. However, variation
in aortic flow following unclamping may play a role
F Fi ig gu ur re e   2 2. . Transit time ultrasound technology (the
principle of Transonic Flowmeter). Using wide beam
illumination, 2 transducers pass ultrasound signals
back and forth, intersecting the flow in upstream
and downstream directions. The flowmeter derives
a measure of the “transit time” it takes for the waves
of ultrasound to travel from one transducer to the
other. The difference between the upstream and
downstream transit time is the measure of the
volume flow
P Pr ro ob be e
b bo od dy y P Pr ro ob be e   b bo od dy y
V Ve es ss se el l
Vessel
Transducer Transducer
Reflector
Cable S Si id de e   v vi ie ew w E En nd d   v vi ie ew w
F Fi ig gu ur re e   3 3. .   Transonic Flowmeter data processor
0=Paraplegia, no movement of the lower limb
1=Paraplegia, slight movement of the lower limb
2=Good movement of the lower limbs but unable
to stand
3=Able to stand, but not able to walk normally
4=Complete recovery
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in development of paraplegia. The studies in this
area may be able to help clarify the causes of
paraplegia development in thoracoabdominal aortic
repairs. The rabbit model is an excellent model
because the segmental distribution of spinal cord
blood supply is similar to that in man.
A significant increase in lower thoracic spinal
cord blood flow in dogs was found compared to the
baseline  flow  after  30  min  of  thoracic  aortic
occlusion [26]. In addition, a significantly greater
degree of hyperemia was noted in those dogs with
neurological deficits compared with that seen in
neurologically intact dogs. Other authors have
correlated a reduction in spinal cord injury with
a reduced hyperemic response during reperfusion
[27].  Oxygen  free  radicals  play  a role  in  the
ischemia/reperfusion-induced  tissue  injury  by
stimulating monocytes to produce TNF-α [28]. On
the other hand, a likely mechanism of neuro-
degeneration following spinal cord injury involves
generation  of  reactive  oxygen  species,  which
overwhelm endogenous antioxidants. In a review
of 858 thoracoabdominal aneurysm repairs (June
1990-June 2006), it was suggested that paraplegia
can result from inadequate postoperative spinal
cord perfusion and delayed paraplegia can perhaps
be prevented with better hemodynamic and fluid
management [7]. Controlled low-pressure perfusion
F Fi ig gu ur re e   4 4. . Neurological outcome of 22-min infrarenal
aortic clamping and declamping. The pie chart above
shows the control group (n = 13), in which 77%
rabbits developed paraplegia (Tarlov 0 and 1, n = 10).
The  pie  chart  below  shows  the  β-agonist
(clenbuterol) group. In contrast to the control group,
only half as many rabbits (38%) developed paraplegia
(Tarlov 0 and 1, n = 5) in this group
C Co on nt tr ro ol l   g gr ro ou up p   ( (n n = =   1 13 3) )
Tarlov 0, n = 9
Tarlov 1, n = 1
Tarlov 2, n = 0
Tarlov 3, n = 1
Tarlov 4, n = 2
β β- -A Ag go on ni is st t   ( (c cl le en nb bu ut te er ro ol l) )   g gr ro ou up p   ( (n n = =   1 13 3) )
Tarlov 0, n = 3
Tarlov 1, n = 2
Tarlov 2, n = 0
Tarlov 3, n = 2
Tarlov 4, n = 6
F Fi ig gu ur re e   5 5. .   Transonic Flowmeter real-time recording of
infrarenal aortic arterial blood flow. Figure 5 A shows
baseline aortic blood flow before clamping. Figu-
re 5 B shows aortic blood flow recording after
declamping. Note that there is a minimal increase
in post-declamping aortic flow. This rabbit showed
complete postoperative recovery
A
B
F Fi ig gu ur re e   6 6. .   Transonic Flowmeter real-time recording of
infrarenal aortic arterial blood flow. Figure 6 A shows
baseline aortic blood flow before clamping. Figu-
re 6 B shows aortic blood flow recording after
declamping. Note that there is a marked increase in
post-declamping aortic blood flow. Experimental
animals  with  this  kind  of  post-declamping
hyperperfusion showed complete postoperative
paraplegia
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at the beginning of reperfusion can attenuate
neurological injury of the spinal cord after transient
ischemia,  and  reperfusion  initiated  with  low-
pressure perfusion exerts neuroprotective effects
on the spinal cord against ischemia/reperfusion
injury [29].
Cerebrospinal fluid IL-8 levels are significantly
elevated in thoracoabdominal aortic operation, and
persistent elevation of CSF IL-8 levels may be
predictive of further development of neurological
deficits  [30].  Oxidative  stress  induces  cyclo  -
oxygenase-2  (COX-2)  activity  in  neurons  after
various CNS insults, including global ischemia [31].
The COX-2 inhibitors SC-58125 and NS-398 have
been  shown  to  prevent  delayed  death  of
hippocampal neurons and to reduce infarct size
after global ischemia [32, 33].
The importance of reperfusion injury in spinal
cord dysfunction has been suggested, especially as
pertains to delayed-onset paraplegia [34, 35]. The
prevalence of paraplegia after descending thoracic
aorta cross-clamping in a dog model was reduced
by administration of the enzymatic antioxidant
superoxide dismutase, implicating oxidants as one
cause of the injury [36]. Ischemic reperfusion injury
of  the  spinal  cord  occurs  due  to  temporary
interruption of the blood supply to the spinal cord.
This may result in irreversible vascular injuries with
subsequent paraplegia or other neurological deficits
[37].  Oxidative  stress  with  overproduction  of
reactive  oxygen  species,  such  as  free  radicals 
and  peroxides,  is  incriminated  in  neurological
vascular injuries [38]. Activated protein C (APC)
reduced the ischemia/ reperfusion-induced spinal
cord injury by inhibiting neutrophil activation. The
therapeutic mechanisms of APC might depend on
its inhibitory effect on the production of TNF-α,
which is a potent activator of neutrophils [39].
Neuroprotection by clenbuterol has been shown
in vivo and in vitro [40-42]. Clenbuterol caused an
increase in glutathione reductase activity; this
suggests that activation of β2-adrenoreceptors
during  the  acute  phase  of  injury  stimulates
glutathione-dependent antioxidative processes that
lead to reduced oxidative damage and greater
locomotor function as the injury evolves during the
subacute and chronic phases [43]. It has been found
that clenbuterol plays a key role in the cardiac
protection against myocardium I/R injury [44].
Moreover, clenbuterol induces nerve growth factor
synthesis in cultured hippocampal cells and protects
hippocampal neurons against excitotoxic damage.
The neuroprotective activity of clenbuterol is also
demonstrated in vivo in two rodent models of
cerebral  ischemia.  There  is  evidence  that  the
neuroprotective activity of clenbuterol is caused by
activation  of  β-adrenergic  receptors  and  the
subsequent increased expression of nerve growth
factor [45]. In addition, clenbuterol has been shown
to have neuroprotective activity after transient
forebrain ischemia through increasing nerve growth
factor expression [46-48]. Thus, the stimulation of
the β2-adrenoreceptor seems to play an important
role in activating nerve growth factor against neural
damage. Clenbuterol has been shown to spare
spinal cord tissue and enhance locomotor recovery
in an experimental model of spinal cord contusion
injury.
It has been shown that nerve growth factor
mediated  the  neuroprotective  effects  of  the
β2-adrenoceptor agonist clenbuterol in vitro and in
vivo [41, 49, 50]. The increase in the ratio of Bcl-2
and Bax may contribute to the anti-apoptotic effect
of clenbuterol [51]. Clenbuterol has anti-inflam  -
matory and neurotrophic actions and elicits a neuro-
protective effect in the kainic acid (KA) model of
neurodegeneration [52]. Clenbuterol treatment
activated cAMP response element binding protein
within retrogradely traced neurons, which has been
associated with axonal regrowth. Chondroitinase
ABC and clenbuterol can act synergistically to
promote recovery of locomotor function [53].
Clenbuterol suppressed LPS-induced expression
of the inflammatory cytokines TNF-α and IL-6, the
inflammatory chemokines RANTES and IP-10, and
the co-stimulatory molecules CD40 and ICAM-1.
Thus overall, clenbuterol suppresses the innate
inflammatory response in rat brain [54]. It was
shown  that  a novel  mechanism  of  action  of 
β2-adrenoceptor  agonists  and  suggested  that
increased formation of the endogenous glutamate
receptor antagonist kynurenic acid could partially
contribute to their neuroprotective activity [55].
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